Rehovot, Israel-based Plantish is developing a plant-based analog whole-cut salmon fillet.
The six-month-old company is developing a versatile, patent-pending manufacturing technology that will produce plant-based fish alternatives at low-cost and high-scale, the company said in a press release.
Its first product, Plantish Salmom, is a fully structured, boneless salmon fillet, which sports the same nutritional value as conventional salmon, and is high in protein, omega-3s, omega-6s, and vitamin B, according to Plantish.
"Our vision is to be the world's leading seafood brand, all without hurting a single fish,” Plantish Chief Scientific Officer Ron Sicsic said. "We exist to save the oceans and eliminate the need to consume marine animals by providing more-sustainable, more-nutritious, and more-delicious fish options.”
The plant-based analog mimics cooked salmon in texture, taste, appearance and structure, the company said.
Using the right plant proteins to achieve the fibrous strands meant to replicate the complex texture of animal muscle is the key to succeeding in capturing the experience of eating salmon, according to the supplier.
Plantish is “doing so at scale will make it a suitable substitute for foodservice, restaurants, and retail,” the company said.
Plantish’s salmon analog product will be launching in select pop-up locations by the end of 2022. Its official launch is expected in 2024.
Plantish raised a pre-seed funding round of USD 2 million (EUR 1.7 million) from TechAviv Founder Partners.
The total number of companies developing alternative fish and seafood products grew by 30 percent between 2017 and 2020, according to IMARC.
Photo courtesy of Plantish
